文献速递关节外科

诊断慢性假体周围感染时的实验室检查有助于预测二期翻修术的结局

Laboratory Tests for Diagnosis of Chronic Periprosthetic Joint Infection Can Help Predict Outcomes of Two-Stage Exchange.
PubMed 文献 · J Bone Joint Surg Am · 2018-01-01

该研究纳入4家机构205例因全髋或全膝关节置换术后假体周围感染接受二期翻修术的患者,比较感染复发翻修者与未复发者的术前实验室指标。术前滑液白细胞计数>60,000个/μL、滑液白细胞中性粒细胞百分比>92%及血清红细胞沉降率>99 mm/hr者二期翻修失败风险分别为2.5倍、2.0倍和1.8倍。

要点

  • 二期翻修术总体失败率为27.3%。
  • 术前滑液白细胞计数>60,000个/μL者失败可能性为2.5倍。
  • 术前滑液白细胞中性粒细胞百分比>92%者失败可能性为2.0倍,血清红细胞沉降率>99 mm/hr者失败可能性为1.8倍。

核心结论

  • 二期翻修术最终失败的患者中,更多患者术前滑液白细胞计数>60,000个/μL、滑液白细胞中性粒细胞百分比>92%或血清红细胞沉降率>99 mm/hr。
  • 实验室指标升高的患者治疗失败风险为1.8至2.5倍。
  • 这些数据可作为临床指南,用于识别二期翻修术失败风险最高的患者。

研究设计与样本

  • 研究纳入4家机构205例因全髋或全膝关节置换术后假体周围感染接受二期翻修术的患者。
  • 从病历中获取人口学、手术和实验室数据,实验室指标包括血清红细胞沉降率、血清C反应蛋白水平、滑液白细胞计数和中性粒细胞百分比、滑液和/或组织培养及革兰染色。
  • 因感染复发接受翻修手术的患者被视为二期翻修术失败。
  • 比较两组间人口学、手术和实验室变量,构建受试者工作特征(ROC)曲线确定显著实验室指标的阈值,计算风险比和95%置信区间。
  • 证据等级为治疗性IV级。

主要发现

  • 总体而言,27.3%的患者二期翻修术未成功。
  • 感染复发患者的术前血清红细胞沉降率(p = 0.035)、滑液白细胞计数(p = 0.008)和中性粒细胞百分比(p = 0.041)更高。
  • ROC曲线分析显示滑液白细胞计数阈值为>60,000个/μL,滑液白细胞中性粒细胞百分比阈值为>92%,血清红细胞沉降率阈值为>99 mm/hr。
  • 术前滑液白细胞计数升高者二期翻修失败可能性为2.5倍,术前滑液白细胞中性粒细胞百分比升高者为2.0倍,术前血清红细胞沉降率升高者为1.8倍。

关键数值与推荐

  • 滑液白细胞计数阈值>60,000个/μL。
  • 滑液白细胞中性粒细胞百分比阈值>92%。
  • 血清红细胞沉降率阈值>99 mm/hr。
  • 术前滑液白细胞计数升高者失败风险比为2.5,滑液白细胞中性粒细胞百分比升高者为2.0,血清红细胞沉降率升高者为1.8。

临床怎么用

  • 原文结论指出这些数据可作为临床指南,用于识别二期翻修术失败风险最高的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although 2-stage exchange arthroplasty is the most effective treatment among available strategies for managing chronic periprosthetic joint infection (PJI), rates of its success vary greatly. The purpose of our study was to examine whether objective measurements collected at the time of the diagnosis of PJI could be used to identify patients at risk of failure of 2-stage exchange. METHODS: We identified 205 patients across 4 institutions who underwent 2-stage exchange arthroplasty for the treatment of PJI following total hip or total knee arthroplasty. Demographic, surgical, and laboratory data were obtained for each patient from their medical chart. Laboratory values included serum erythrocyte sedimentation rate (ESR), serum C-reactive protein (CRP) level, synovial fluid white blood-cell (WBC) count and neutrophil percentage, synovial fluid and/or tissue culture, and Gram stain. Patients who underwent revision surgery for recurrent infection were considered to have failed the 2-stage procedure. Demographic, surgical, and laboratory variables were compared between the 2 groups. Receiver operating characteristic (ROC) curves were constructed to determine threshold cutoffs for significant laboratory values. Risk ratios and 95% confidence intervals were calculated. RESULTS: Overall, 2-stage exchange was unsuccessful for 27.3% of the patients. Preoperative serum ESR (p = 0.035) and synovial fluid WBC count (p = 0.008) and neutrophil percentage (p = 0.041) were greater in patients with recurrent infection. ROC curve analysis revealed a threshold of >60,000 cells/μL for synovial fluid WBC count, >92% for synovial fluid WBC neutrophil percentage, and >99 mm/hr for serum ESR. Failure of 2-stage exchange was 2.5 times more likely for patients with an elevated preoperative synovial fluid WBC count, 2.0 times more likely for those with an elevated preoperative synovial fluid WBC neutrophil percentage, and 1.8 times more likely for those with an elevated preoperative serum ESR. CONCLUSIONS: Our results demonstrated that a greater number of patients in whom 2-stage exchange arthroplasty ultimately failed had a preoperative synovial fluid WBC count of >60,000 cells/μL, a synovial fluid WBC neutrophil percentage of >92%, or a serum ESR of >99 mm/hr. Patients with elevated laboratory values had 1.8 to 2.5 times the risk of treatment failure. These data can serve as a clinical guideline to identify patients most at risk for failure of 2-stage exchange. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Dwyer MK, Damsgaard C, Wadibia J, et al. Laboratory Tests for Diagnosis of Chronic Periprosthetic Joint Infection Can Help Predict Outcomes of Two-Stage Exchange. J Bone Joint Surg Am. 2018. PMID: 29916927. doi:10.2106/JBJS.17.00599

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。